2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theCardiac Prosthetic Devices Market from 2025 to 2034?
The upward trajectory of the cardiac prosthetic devices market is expected to be fuelled by the increasing occurrence of cardiovascular diseases. These diseases, encompassing a variety of disorders that affect the heart and blood vessels, include conditions such as coronary artery disease, heart attacks, and strokes. The surge in these diseases can be attributed to unhealthy lifestyles, widespread obesity, poor diet, lack of exercise, high levels of stress, and an ageing population. Cardiac prosthetic devices are pivotal in managing these diseases as they aid or take over the function of the heart or its parts. For instance, the British Heart Foundation, a UK-based cardiovascular research charity, reported in January 2024 that about 7.6 million people in the UK are affected by heart and circulatory diseases. This includes nearly 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or an average of 480 deaths each day, which equates to one death every three minutes. Therefore, the rising incidence of cardiovascular diseases is fuelling the growth of the cardiac prosthetic devices market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18283&type=smp
#What Long-Term Growth Rate is Expected for theCardiac Prosthetic Devices Market Between 2025 and 2034?
In recent years, the cardiac prosthetic devices market has seen a significant expansion. The market, valued at $8.2 billion in 2024, is projected to grow to $9.15 billion in 2025, with a compound annual growth rate (CAGR) of 11.5%. Key drivers behind this growth include an aging population susceptible to cardiovascular diseases, a rising number of cardiovascular disease incidents, enhancements in surgical procedures, heightened awareness of cardiac health amongst patients and medical professionals, as well as supportive policies and funding from government for cardiovascular health initiatives.
Anticipated to experience swift expansion in the forthcoming years, the cardiac prosthetic devices market is expected to surge to a value of $13.97 billion in 2029, with a compound annual growth rate (CAGR) of 11.2%. This predicted growth in the upcoming period is mainly due to factors like the rise in the aging population susceptible to cardiovascular diseases, increased expenditure on healthcare services and products, favorable insurance and reimbursement circumstances, growing patient preference for advanced therapeutic alternatives, and a heightened occurrence of lifestyle-induced heart ailments. Noteworthy trends during the forecast period consist of the invention of smaller, highly efficient cardiac prosthetic devices compatible with minimally invasive surgeries, advancement in biocompatible materials, incorporation of wearable technology, enhancements in battery technology, and the use of 3D printing technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18283
How Are Market Trends and Innovations Revolutionizing theCardiac Prosthetic Devices Industry in Recent Times?
Prominent firms in the cardiac prosthetic devices market are concentrating on developing ground-breaking technologies like transcatheter pacing systems. These systems aim to boost cardiac functionality, diminish procedural invasiveness, and augment patient results dealing with heart rhythm issues. The transcatheter pacing system is a non-invasive device placed through a catheter to control the heart’s electrical activity, eliminating the need for external wires or surgery. For example, Medtronic plc, an Irish-based medical device corporation, in January 2022 introduced the Micra AV Transcatheter Pacing System. This system is small, minimally intrusive and specifically designed for treating bradycardia (slow heart rate). The Micra AV TPS is developed to provide accurate and dependable pacing for people suffering from bradycardia, encompassing advanced technology to align pacing with the heart’s natural rhythm. Its petite size and internal battery enhance durability, and the remote monitoring features allow medical experts to manage the device’s operation and patient results more efficaciously.
Which Key Market Players Are Shaping the Future and Growth of theCardiac Prosthetic Devices Market?
Major companies operating in the cardiac prosthetic devices market are Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Terumo Corporation, Edwards Lifesciences Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Hansen Medical Inc., Abiomed Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, ATRICURE INC., CryoLife Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Venus Medtech (Hangzhou) Inc., Braile Biomedica, Kawasumi Laboratories Inc., St. Jude Medical Inc., Sorin Group, Aortic Innovations Inc., Mic Pacetronixro
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report
What Are the Core Segments of the Cardiac Prosthetic Devices Market, and How Do They Contribute to Growth?
The cardiac prosthetic devices market covered in this report is segmented –
1) By Type: Valves, Pacemakers
2) By Applications: Surgery, Research
3) By End User: Hospitals, Clinics Or Cardiac Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Valves: Mechanical Valves, Tissue Valves, Transcatheter Heart Valves
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=18283&type=smp
What Regions Are Dominating the Cardiac Prosthetic Devices Market Growth?
North America was the largest region in the cardiac prosthetic devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac prosthetic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Cardiac Prosthetic Devices Market 2025, By The Business Research Company:
Implantable Cardiac Rhythm Management Device Global Market Report 2024
Cardiac Biomarkers Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Cardiac Arrhythmia Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
